L & S Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,049
Closed -$2.47M 334
2017
Q3
$2.47M Sell
12,049
-1,262
-9% -$293K 0.41% 73
2017
Q2
$3.24M Buy
13,311
+186
+1% +$43.7K 0.57% 52
2017
Q1
$3.14M Buy
+13,125
New +$3.06M 0.6% 50
2016
Q4
Sell
-6,973
Closed -$1.61M 189
2016
Q3
$1.61M Buy
+6,973
New +$1.7M 0.44% 61
2016
Q1
Sell
-19,370
Closed -$6.05M 109
2015
Q4
$6.05M Buy
19,370
+12,163
+169% +$3.62M 1.52% 23
2015
Q3
$1.96M Sell
7,207
-6,876
-49% -$2.11M 0.57% 60
2015
Q2
$4.27M Buy
14,083
+138
+1% +$41.2K 1.09% 38
2015
Q1
$4.15M Buy
+13,945
New +$3.98M 1.09% 38
2014
Q2
Sell
-10,023
Closed -$2.06M 103
2014
Q1
$2.06M Sell
10,023
-23,887
-70% -$4.73M 1.1% 33
2013
Q4
$5.7M Sell
33,910
-4,878
-13% -$763K 2.07% 7
2013
Q3
$5.58M Sell
38,788
-927
-2% -$123K 2.26% 7
2013
Q2
$5.01M Buy
+39,715
New +$4.5M 2.45% 9

Other funds holding AGN

L & S Advisors's AGN Position: Q4 2017 in Review

L & S Advisors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 12,049 shares — an estimated $2.47M sold.

L & S Advisors first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $6.05M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • L & S Advisors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • L & S Advisors sold 12,049 Allergan plc shares in Q4 2017, an estimated $2.47M.
  • L & S Advisors first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • L & S Advisors's Allergan plc position peaked at $6.05M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on L & S Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.